08:00 , Jan 2, 2012 |  BC Week In Review  |  Clinical News

Transdermal ibuprofen-VALE cream: Phase II data

A double-blind, Swiss Phase II trial in 75 patients with moderate to severe OA of the knee showed that twice-daily BC-IBU-CH-001 significantly reduced pain as measured by WOMAC pain scores from baseline to day 14...
07:00 , Jun 9, 2008 |  BC Week In Review  |  Company News

BioChemics Inc. scientific advisory board update

BioChemics Inc. , Danvers, Mass.   Business: Drug delivery   Appointed: R. Rox Anderson, professor at Harvard Medical School, adjunct professor at the Massachusetts Institute of Technology and director of the Wellman Center for Photomedicine...
07:00 , Apr 26, 2004 |  BioCentury  |  Regulation

Tag team wrestling

Regulation Tag team wrestling Increased collaboration between FDA and SEC, fallout from the ImClone Systems Inc. case, and investor demands for more information about early-stage drug development, are contributing to an intensification of SEC's scrutiny...